1-5 of 5
Dennis T. Villareal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

STAT1 Dissociates Adipose Tissue Inflammation From Insulin Sensitivity in Obesity

Aaron R. Cox, Natasha Chernis, David A. Bader, Pradip K. Saha, Peter M. Masschelin, Jessica B. Felix, Robert Sharp, Zeqin Lian, Vasanta Putluri, Kimal Rajapakshe, Kang Ho Kim, Dennis T. Villareal, Reina Armamento-Villareal, Huaizhu Wu, Cristian Coarfa, Nagireddy Putluri, Sean M. Hartig
Journal: Diabetes
Diabetes 2020;69(12):2630–2641
https://doi.org/10.2337/db20-0384
Published: 29 September 2020
View article titled, STAT1 Dissociates Adipose Tissue Inflammation From Insulin Sensitivity in Obesity
Open the PDF for STAT1 Dissociates Adipose Tissue Inflammation From Insulin Sensitivity in Obesity in another window
Journal Articles

Xenin-25 Amplifies GIP-Mediated Insulin Secretion in Humans With Normal and Impaired Glucose Tolerance but Not Type 2 Diabetes

Burton M. Wice, Dominic N. Reeds, Hung D. Tran, Dan L. Crimmins, Bruce W. Patterson, Judit Dunai, Michael J. Wallendorf, Jack H. Ladenson, Dennis T. Villareal, Kenneth S. Polonsky
Journal: Diabetes
Diabetes 2012;61(7):1793–1800
https://doi.org/10.2337/db11-1451
Published: 15 June 2012
View article titled, Xenin-25 Amplifies GIP-Mediated Insulin Secretion in Humans With Normal and Impaired Glucose Tolerance but Not Type 2 Diabetes
Open the PDF for Xenin-25 Amplifies GIP-Mediated Insulin Secretion in Humans With Normal and Impaired Glucose Tolerance but Not Type 2 Diabetes in another window
Journal Articles

Response letter to comment on: Villareal et al. (2009) TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action. Diabetes; 59:479–485

Dennis T. Villareal, Kenneth S. Polonsky
Journal: Diabetes
Diabetes 2010;59(6):e5–e6
https://doi.org/10.2337/db10-0303
Published: 01 June 2010
View article titled, Response letter to comment on: Villareal et al. (2009) TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action. Diabetes; 59:479–485
Open the PDF for Response letter to comment on: Villareal et al. (2009) TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action. Diabetes; 59:479–485 in another window
Journal Articles

TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action

Dennis T. Villareal, Heather Robertson, Graeme I. Bell, Bruce W. Patterson, Hung Tran, Burton Wice, Kenneth S. Polonsky
Journal: Diabetes
Diabetes 2010;59(2):479–485
https://doi.org/10.2337/db09-1169
Published: 23 November 2009
View article titled, TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action
Open the PDF for TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action in another window
Journal Articles

Kir6.2 Variant E23K Increases ATP-Sensitive K+ Channel Activity and Is Associated With Impaired Insulin Release and Enhanced Insulin Sensitivity in Adults With Normal Glucose Tolerance

Dennis T. Villareal, Joseph C. Koster, Heather Robertson, Alejandro Akrouh, Kazuaki Miyake, Graeme I. Bell, Bruce W. Patterson, Colin G. Nichols, Kenneth S. Polonsky
Journal: Diabetes
Diabetes 2009;58(8):1869–1878
https://doi.org/10.2337/db09-0025
Published: 02 June 2009
View article titled, Kir6.2 Variant E23K Increases ATP-Sensitive K<sup>+</sup> Channel Activity and Is Associated With Impaired Insulin Release and Enhanced Insulin Sensitivity in Adults With Normal Glucose Tolerance
Open the PDF for Kir6.2 Variant E23K Increases ATP-Sensitive K<sup>+</sup> Channel Activity and Is Associated With Impaired Insulin Release and Enhanced Insulin Sensitivity in Adults With Normal Glucose Tolerance in another window
Includes: Supplementary data